Basic Information
Basic information for C21orf62-AS1-203-31aa
Peptide Name C21orf62-AS1-203-31aa
Genome Position chr21:32797280-32797372[+]
Species Human
Peptide Sequence MKSPGLQFSGAISAHCKLCLPGSNDCLVSAS
Peptide Length 31
Unique No (C21orf62-AS1-201-31aa,C21orf62-AS1-202-31aa,C21orf62-AS1-206-31aa)
Grand Average of Hydropathicity 0.3484
Relative Molecular Mass 3663.07
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000382378;C21orf62-AS1-203
Transcript Length 3352
Coding Ability 0.4538
DNA Sequence Corresponding to Peptide ATGAAGTCGCCCGGGCTGCAGTTCAGTGGTGCAATCTCAGCTCACTGCAAGCTCTGCCTCCCAGGTTCCAACGATTGTCTTGTCTCAGCCTCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :